100 Companies in Contract Pharmaceutical Research – White Paper

    Published: March 27, 2018 | Price: $0

    This brief White Paper lists over one hundred companies that are involved in drug discovery in one form or another.  A company website and address is provided for each company.  The White Paper does not detail companies or discuss the CRO marketplace - for this purpose, please consult our recent report, Outsourcing in Drug Discovery, 8th Edition.
    Biopharmaceutical Contract Manufacturing (BCMO) Market – by Type of Service, by Organization and by Region

    Published: November 29, 2017 | Price: $3,600 – $7,200

    Estimating Market Size, Market Share, and Market Opportunity for Biopharmaceutical Contract Manufacturing Organizations    Over the past several years, an unprecedented number of blockbuster drugs have lost patent protection, and this trend is expected to continue through the foreseeable future. Yet pharmaceutical companies cannot always produce their needed pipeline in-house.  This has created an ideal market environment for biopharmaceutical contracting. This report, Biopharmaceutical Contract Manufacturing Market (BCMO) Market by Type of Service, by Organization and by Region, contains the following...
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, Forecasts to 2018, 6th Edition

    Published: April 30, 2014 | Price: $995 – $1,990

    For six editions, this authoritative resource has defined the market opportunity for companies assisting in the beginning phase of the drug development process. This Kalorama Information Report, Outsourcing in Drug Discovery, t provides an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for the following segments. Chemistry Services Market: Building Blocks, Compound Synthesis, Libraries,...
    Early Toxicology: Markets and Approaches

    Published: September 12, 2012 | Price: $3,995 – $7,990

    Early toxicology testing is emerging as one of the mostsignificant areas of drug discovery. Toxicity is no longer something that can be left to the development stage, or just a small part of ADMET. Toxicity determinations are an integral part of all aspects of drug discovery & development. This report, Early Toxicology Markets and Approaches, focuses on markets for early toxicology testing services. The objective of this report is to focus the reader’s attention on the issues and opportunities related...
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition

    Published: May 11, 2012 | Price: $3,995 – $7,990

    The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a target protein or nucleic acid in a way that is useful for treatment of disease. The process by which molecules are identified for their therapeutic value involves synthesis and analysis of many derivatives of the original leads. There are several steps in the drug discovery...
    Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition

    Published: June 1, 2010 | Price: $3,995 – $7,990

    Kalorama Information's Outsourcing in Drug Discovery offers unparalleled discussion of the drug discovery outsourcing market. It presents viewpoints from both customers and suppliers. Segments, size, and growth of the market are presented. The trend toward the increased use of offshore suppliers is covered in detail. The report also provides profiles of 22 suppliers, representative of those active in this market. Segments covered in this report include: Chemistry Services Building Blocks Compound Synthesis Libraries Process Research Other Services Biology Services Protein...
    Pharmaceutical Markets in India

    Published: April 1, 2009 | Price: $995 – $2,590

    The pharmaceutical market in India ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be essential for pharmaceutical companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This report Pharmaceutical Market in India provides market watchers with needed information on this growing market, including:   Market Size and Forecast...
    Pharmaceutical Markets in Russia

    Published: January 1, 2009 | Price: $995 – $1,990

    The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets. For the...
    Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)

    Published: November 1, 2008 | Price: $995 – $1,990

    At present the Middle East region constitutes as small percent of global pharmaceutical sales. However, ever-increasing populations and governmental healthcare reforms are likely to increase demand. These markets will be essential for pharmaceuticals companies exploring new opportunities for growth. Developing regions will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. This Kalorama Information report, Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends) takes a thorough look at the...
    Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )

    Published: July 1, 2008 | Price: $500 – $7,000

    Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. Kalorama's Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a...
    Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition

    Published: May 1, 2008 | Price: $3,500 – $7,000

    2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent protection for many drug product. And there is also pressure to reduce the time spent in drug discovery and to bring drugs to market sooner, as well as the ever-present cost considerations....
    Pharmaceutical Excipients for Oral Formulations, 2nd. Edition

    Published: February 1, 2008 | Price: $995 – $7,990

    Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to the pharmaceuticals, aid the innovations in the drug development and help improve patent life as well. Excipients make the products more functional at a lower cost, a benefit much desired by the pharmaceutical industry that is inundated with pressures to reduce costs. All in all, excipients...
    Pharmaceutical Outsourcing Opportunities Post-Launch – Contract Manufacturing and Contract Sales and Marketing, 2nd Edition

    Published: September 1, 2006 | Price: $3,900 – $7,800

    This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. The report contains vital market statistics on three main segments of pharmaceutical contract manufacturing: Biopharmaceutical manufacturing, including monoclonal antibodies (MAbs), complex proteins, peptides, nucleotides, DNA vaccines, and gene therapy. Primary pharmaceutical manufacturing, including non-sterile and sterile active pharmaceutical ingredients (APIs), custom chemicals, certain specialized manufacturing...
    Pharmaceutical Outsourcing Opportunities Post Launch: Contract Manufacturing, and Sales and Marketing

    Published: July 1, 2004 | Price: $3,500 – $7,000

    After decades of sustained growth and profitability, the pharmaceutical industry has been positioned as one of the few recession proof industries based on its performance through multiple economical cycles. In recent years, there have been visible strains in the pharmaceutical business. With a downturn in fortunes, many pharmaceutical companies are searching for business solutions to streamline operations and cut costs as they strive to continue generating above-average shareholder returns. Outsourcing has become an integral, ongoing element of pharmaceutical companies’ business...
    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    Published: January 1, 2004 | Price: $3,500 – $7,000

    The cost of drug development has soared during the past ten years compelling pharmaceutical and biotechnology companies to look for new, smarter ways of conducting clinical research. Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. This industry has evolved from providing limited clinical trial services...